TGA Plans to Auto-Approve Low-Risk Product Variations

The Australian Therapeutic Goods Administration issued an industry guidance proposing to quickly approve certain types of low-risk variations to registered medicines without requiring evaluation, allowing sponsors to implement the changes immediately.
Source: International Pharmaceutical Regulatory Monitor